Levo Therapeutics

About:

Levo Therapeutics is a biomedical research and development services intended to treat the multisystem neurodevelopmental disorder.

Website: https://www.levotx.com/

Twitter/X: levothera

Top Investors: Samsara BioCapital

Description:

Levo Therapeutics is a biomedical research and development services intended to treat the multisystem neurodevelopmental disorder. The company's research and development services are dedicated to using genetic insights to advance treatments for Prader-Willi syndrome and related disorders, enabling patients to get cured of severe neurodevelopmental disorders.

Total Funding Amount:

$40M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Skokie, Illinois, United States

Founded Date:

2016-01-01

Founders:

Sara Cotter

Number of Employees:

1-10

Last Funding Date:

2019-11-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai